A. M. President Donald Trump announced that his administration will impose a “significant tariff” on pharmaceutical products manufactured outside the country as part of his strategy to reindustrialize the United States and reduce dependence on foreign supply chains, especially China.
During a National Republican Congressional Committee event, Trump asserted that most drugs sold in the country are produced abroad, and that the new tariffs will seek to force pharmaceutical companies to move their production plants to the United States.
“Companies will be leaving China and other places because they will have to sell in the United States, and to do that, they will have to open their plants all over our country”, the president stated, highlighting the positive impact this measure would have on jobs and the local economy.
Trump also emphasized that the decision on a possible trade de-escalation with China now rests with Beijing, making it clear that his administration will continue to apply pressure through new rounds of tariffs, not only on medicines but also on low-value products imported from the Asian country.
The measure is part of the president’s nationalist economic strategy, which has been the cornerstone of his reelection campaign and his foreign trade policy, aiming to strengthen US industry and reduce the trade deficit.
